The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems

被引:3
作者
Hu, Xiangyan [1 ]
Huang, Sisi [1 ,2 ]
Ye, Shiying [1 ]
Jiang, Jinhuan [1 ,3 ]
机构
[1] Univ South China, Hengyang Med Sch, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang 421001, Hunan, Peoples R China
[2] Fudan Univ, Pharm Sch, Shanghai Inst Biomed & Pharmaceut Technol, NHC Key Lab Reprod Regulat, Shanghai 200032, Peoples R China
[3] Univ South China, Hengyang Med Sch, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, Hengyang 421001, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
Oridonin; anticancer; molecular mechanism; signaling pathway; herbal medicine; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; INHIBITS MIGRATION; MELANOMA-CELLS; CANCER GROWTH; APOPTOSIS; AUTOPHAGY; PATHWAY; CARCINOMA; INVASION;
D O I
10.2174/1389201024666230821110116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oridonin, an active diterpenoid isolated from traditional Chinese herbal medicine, has received a rising attention for its remarkable roles in cancer therapy. In recent years, increasing evidences have revealed that oridonin inhibits the occurrence and development of tumor cells through multiple mechanisms, including induction of apoptosis and autophagy, cell cycle arrest, and inhibition of angiogenesis as well as migration and invasion. In addition, several molecular signal targets have been identified, including ROS, EGFR, NF-kappa B, PI3K/Akt, and MAPK. In this paper, we review considerable knowledge about the molecular mechanisms and signal targets of oridonin, which has been studied in recent years. It is expected that oridonin may be developed as a novel anti-tumor herbal medicine in human cancer treatment.
引用
收藏
页码:655 / 664
页数:10
相关论文
共 88 条
  • [11] Oridonin inhibits the occurrence and development of colorectal cancer by reversing the Warburg effect via reducing PKM2 dimer formation and preventing its entry into the nucleus
    Chen, Fan
    Liao, Junnan
    Wu, Pinghui
    Cheng, Li
    Ma, Yingchao
    Zhang, Linghan
    Leng, Xiaomin
    Zhu, Xiuzhi
    Liu, Zhiping
    Xie, Fuhua
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 954
  • [12] Oridonin Inhibits Mycobacterium marinum Infection-Induced Oxidative Stress In Vitro and In Vivo
    Chen, Guangxin
    Yang, Ziyue
    Wen, Da
    Li, Ping
    Xiong, Qiuhong
    Wu, Changxin
    [J]. PATHOGENS, 2023, 12 (06):
  • [13] Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer
    Chen, Kunlun
    Ye, Jianwen
    Qi, Lei
    Liao, Yuan
    Li, Renfeng
    Song, Shengping
    Zhou, Chuang
    Feng, Ruo
    Zhai, Wenlong
    [J]. ANTI-CANCER DRUGS, 2019, 30 (09) : 925 - 932
  • [14] Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility
    Ding, Chunyong
    Zhang, Yusong
    Chen, Haijun
    Yang, Zhengduo
    Wild, Christopher
    Chu, Lili
    Liu, Huiling
    Shen, Qiang
    Zhou, Jia
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (12) : 5048 - 5058
  • [15] Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells
    Dong, Xinjun
    Liu, Feiyan
    Li, Mianli
    [J]. ANTI-CANCER DRUGS, 2016, 27 (04) : 286 - 299
  • [16] Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling
    Dong, Yanmin
    Zhang, Tao
    Li, Jingjie
    Deng, Huayun
    Song, Yajuan
    Zhai, Dong
    Peng, Yi
    Lu, Xiaoling
    Liu, Mingyao
    Zhao, Yongxiang
    Yi, Zhengfang
    [J]. PLOS ONE, 2014, 9 (12):
  • [17] Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer
    Donohoe, Fionan
    Wilkinson, Michael
    Baxter, Eva
    Brennan, Donal J.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [18] Du YQ, 2019, J BUON, V24, P1175
  • [19] Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis via Targeting Thioredoxin Reductase
    Duan, Dongzhu
    Feng, Xiaolu
    Pan, Dabo
    Wang, Le
    Wang, Yanru
    Wang, Xiaoling
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (14) : 1647 - 1657
  • [20] Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway in ovarian cancer
    Fan, Xiaoye
    Xie, Min
    Zhao, Feijie
    Li, Jiajia
    Fan, Changqing
    Zheng, Hao
    Wei, Zhentong
    Ci, Xinxin
    Zhang, Songling
    [J]. PHYTOMEDICINE, 2021, 82